LENSAR (LNSR) vs Microbot Medical (MBOT)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
LENSAR (LNSR) has outperformed Microbot Medical (MBOT) over the past year, losing 47.0% versus a loss of 67.5%. Over five years, LNSR leads with a -14.2% price change compared with -85.1% for MBOT. LENSAR is the larger company by market cap ($78.3 million vs $71.9 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | LNSR | MBOT |
|---|---|---|
| Share price | $6.37 | $1.07 |
| Market cap | $78.26M | $71.87M |
| 1-day change | -1.24% | 0.00% |
| YTD return | -44.54% | -46.50% |
| 1-year return | -47.04% | -67.48% |
| 5-year return | -14.23% | -85.08% |
| P/E ratio (TTM) | 35.39 | — |
| EPS (TTM) | $0.18 | $-0.25 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $12.94 | $3.17 |
| 52-week low | $4.95 | $1.05 |
| Distance from 52-week high | -50.77% | -66.25% |
| Analyst consensus | strong_buy | strong_buy |
| Avg. price target upside | +77.86% | +491.59% |
| Average volume | 102.04K | 649.10K |
| Shares outstanding | 12.29M | 67.16M |
| Employees | 150 | 43 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- LNSR has outperformed MBOT by 20.4 percentage points over the past year.
About LENSAR
LNSR stock →LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing laser systems for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism in the United System, Europe, Asia, South Korea, and internationally. The company offers the LENSAR Laser System, which incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes by providing imaging, procedure planning, design, and precision.
Health Care · Medical/Dental Instruments · 150 employees
About Microbot Medical
MBOT stock →Microbot Medical Inc. is a medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space.
Health Care · Medical/Dental Instruments · 43 employees
LNSR vs MBOT FAQ
Which is bigger, LENSAR or Microbot Medical?
LENSAR (LNSR) is larger, with a market capitalization of $78.26M compared with $71.87M for Microbot Medical (MBOT).
Which stock has performed better over the past year, LNSR or MBOT?
LNSR returned -47.04% over the past 12 months, compared with -67.48% for MBOT (price return, excluding dividends). Past performance does not predict future results.
Are LENSAR and Microbot Medical in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.